|
1
|
HarjačEk M, Lamot L, Bukovac LT, Vidović
M and Joos R: Juvenile SpondyloarthritisChallenges in Rheumatology.
INtech; London, UK: pp. 89–128. 2011
|
|
2
|
Lamot L, Borovecki F, Bukovac Tambic L,
Vidovic M, Perica M, Gotovac K and Harjacek M: Aberrant expression
of shared master-key genes contributes to the immunopathogenesis in
patients with juvenile spondyloarthritis. PLoS One. 9:e1154162014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weiß A, Minden K, Listing J, Foeldvari I,
Sieper J and Rudwaleit M: Course of patients with juvenile
spondyloarthritis during 4 years of observation, juvenile part of
GESPIC. RMD Open. 3:e0003662017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hoving JL, Lacaille D, Urquhart DM, Hannu
TJ, Sluiter JK and Frings-Dresen MH: Non-pharmacological
interventions for preventing job loss in workers with inflammatory
arthritis. Cochrane Database Syst Rev: CD010208. 2014. View Article : Google Scholar
|
|
5
|
Gmuca S and Weiss PF: Juvenile
spondyloarthritis. Curr Opin Rheumatol. 27:364–372. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tse SM and Laxer RM: New advances in
juvenile spondyloarthritis. Nat Rev Rheumatol. 8:269–279. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kitaori T, Ito H, Schwarz EM, Tsutsumi R,
Yoshitomi H, Oishi S, Nakano M, Fujii N, Nagasawa T and Nakamura T:
Stromal cell-derived factor 1/CXCR4 signaling is critical for the
recruitment of mesenchymal stem cells to the fracture site during
skeletal repair in a mouse model. Arthritis Rheum. 60:813–823.
2014. View Article : Google Scholar
|
|
8
|
Wei F, Moore DC, Wei L, Li Y, Zhang G, Wei
X, Lee JK and Chen Q: Attenuation of osteoarthritis via blockade of
the SDF-1/CXCR4 signaling pathway. Arthritis Res Ther. 14:R1772012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Werner L, Guzner-Gur H and Dotan I:
Involvement of CXCR4/CXCR7/CXCL12 interactions in inflammatory
bowel disease. Theranostics. 3:40–46. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eschrich SA and Hoerter AM: Libaffy:
Software for processing Affymetrix GeneChip data. Bioinformatics.
23:1562–1564. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
da Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43:(Database Issue). D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lachmann A, Xu H, Krishnan J, Berger SI,
Mazloom AR and Ma'Ayan A: ChEA: Transcription factor regulation
inferred from integrating genome-wide ChIP-X experiments.
Bioinformatics. 26:2438–2444. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen EY, Tan CM, Kou Y, Duan Q, Wang Z,
Meirelles GV, Clark NR and Ma'ayan A: Enrichr: Interactive and
collaborative HTML5 gene list enrichment analysis tool. BMC
Bioinformatics. 14:1282013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Davis AP, Grondin CJ, Johnson RJ, Sciaky
D, King BL, McMorran R, Wiegers J, Wiegers TC and Mattingly CJ: The
comparative toxicogenomics database: Update 2017. Nucleic Acids
Res. 45:D972–D978. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wade S, Trenkmann M, Mcgarry T, Orr C,
Veale DJ and Fearon U: A8.13 TLR regulated MIR-23A down-regulated
in psoriatic arthritis. Ann Rheum Dis. 75 Suppl 1:(A69): 63–A70.
2016.http://dx.doi.org/10.1136/annrheumdis-2016-209124.166
|
|
21
|
Katsicas MM and Russo R: Biologic agents
in juvenile spondyloarthropathies. Pediatr Rheumatol Online J.
14:172016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo Y, Deng X, Chen S, Yang L, Ni J, Wang
R, Lin J, Bai M, Jia Z, Huang S and Zhang A: MicroRNA-30e targets
BNIP3L to protect against aldosterone-induced podocyte apoptosis
and mitochondrial dysfunction. Am J Physiol Renal Physiol.
312:F589–F598. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Imazu T, Shimizu S, Tagami S, Matsushima
M, Nakamura Y, Miki T, Okuyama A and Tsujimoto Y: Bcl-2/E1B 19
kDa-interacting protein 3-like protein (Bnip3L) interacts with
bcl-2/Bcl-xL and induces apoptosis by altering mitochondrial
membrane permeability. Oncogene. 18:4523–4529. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu W, Wang X, Mei Z, Gong J, Huang L, Gao
X, Zhao Y, Ma J and Qian L: BNIP3L promotes cardiac fibrosis in
cardiac fibroblasts through
[Ca2+]i-TGF-β-Smad2/3 pathway. Sci Rep.
7:19062017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li A, King J, Moro A, Sugi MD, Dawson DW,
Kaplan J, Li G, Lu X, Strieter RM, Burdick M, et al: Overexpression
of CXCL5 is associated with poor survival in patients with
pancreatic cancer. Am J Pathol. 178:1340–1349. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hogan SP, Mishra A, Brandt EB, Royalty MP,
Pope SM, Zimmermann N, Foster PS and Rothenberg ME: A pathological
function for eotaxin and eosinophils in eosinophilic
gastrointestinal inflammation. Nat Immunol. 2:353–360. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ajuebor MN and Swain MG: Role of
chemokines and chemokine receptors in the gastrointestinal tract.
Immunology. 105:137–143. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mei J, Dai N, Liu Y, Hudock K, Liu P,
Deshmukh H, Lee J and Worthen GS: Altered neutrophil homeostasis
and DARC regulate CXCL5-mediated pulmonary immune responses
(INM2P.435). J Immunol. 192 1 suppl:(S56): 182014.
|
|
29
|
Kutty RG, Xin G, Schauder DM, Cossette SM,
Bordas M, Cui W and Ramchandran R: Dual specificity phosphatase 5
is essential for T cell survival. PLoS One. 11:e01672462016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim EK and Choi EJ: Pathological roles of
MAPK signaling pathways in human diseases. Biochim Biophys Acta.
1802:396–405. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lang R, Hammer M and Mages J: DUSP meet
immunology: Dual specificity MAPK phosphatases in control of the
inflammatory response. J Immunol. 177:7497–7504. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Moon SJ, Lim MA, Park JS, Byun JK, Kim SM,
Park MK, Kim EK, Moon YM, Min JK, Ahn SM, et al: Dual-specificity
phosphatase 5 attenuates autoimmune arthritis in mice via
reciprocal regulation of the Th17/Treg cell balance and inhibition
of osteoclastogenesis. Arthritis Rheumatol. 66:3083–3095. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Olsen NJ, Moore JH and Aune TM: Gene
expression signatures for autoimmune disease in peripheral blood
mononuclear cells. Arthritis Res Ther. 6:120–128. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu GS: The functional interactions between
the p53 and MAPK signaling pathways. Cancer Biol Ther. 3:156–161.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
van Rossum MA, Fiselier TJ, Franssen MJ,
Zwinderman AH, ten Cate R, van Suijlekom-Smit LW, van Luijk WH, van
Soesbergen RM, Wulffraat NM, Oostveen JC, et al: Sulfasalazine in
the treatment of juvenile chronic arthritis: A randomized,
double-blind, placebo-controlled, multicenter study. Dutch Juvenile
Chronic Arthritis Study Group. Arthritis Rheum. 41:808–816. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vilca I, Munitis PG, Pistorio A, Ravelli
A, Buoncompagni A, Bica B, Campos L, Häfner R, Hofer M, Ozen S, et
al: Predictors of poor response to methotrexate in
polyarticular-course juvenile idiopathic arthritis: Analysis of the
PRINTO methotrexate trial. Ann Rheum Dis. 69:1479–1483. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Giannini EH, Brewer EJ, Kuzmina N, Shaikov
A, Maximov A, Vorontsov I, Fink CW, Newman AJ, Cassidy JT and Zemel
LS: Methotrexate in resistant juvenile rheumatoid arthritis.
Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled
trial. The Pediatric Rheumatology Collaborative Study Group and The
Cooperative Childr. N Engl J Med. 326:1043–1049. 1992. View Article : Google Scholar : PubMed/NCBI
|
